Login or sign up
For business

AltheRx Pharmaceuticals

3.9· 10 reviews
Average ratingAverage
3.9/ 5

Based on 10 reviews

530%
430%
340%
20%
10%
Ask AI

Ask AI about AltheRx Pharmaceuticals

Generated with AI from 10 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About AltheRx Pharmaceuticals

AltheRx Pharmaceuticals is a privately held, clinical development company focused on advancing best-in-class compounds with high promise in large unmet markets. The Company is focused on clinical development and optimizing commercialization through partnerships. The AltheRx name is a derivative of the name of the Greek goddess of healing, Althea.

The Company’s lead product, Solabegron, is a highly differentiated novel compound being investigated for OAB and IBS, conditions that affect the quality of life for more than 90 million Americans − a number that will grow significantly as the population ages. Solabegron was discovered and first developed by GlaxoSmithKline and acquired by AltheRx in March 2011.

The company’s co-founders have decades of leadership experience in the pharmaceutical and biotechnology industries.

AltheRx was formed in 2010.